{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T06:46:43Z","timestamp":1776235603648,"version":"3.50.1"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Colorectal cancer (CRC) remains a leading cause of cancer-related mortality worldwide, characterized by a highly immunosuppressive tumor microenvironment (TME) that facilitates immune evasion and tumor progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Integrated analysis of TCGA and GEO datasets was performed to evaluate CALB2 expression and its prognostic significance in CRC. Functional experiments including proliferation, migration, colony formation, and apoptosis assays were conducted following CALB2 knockdown. Co-culture assays and multiplex immunohistochemistry (mIHC) were used to assess TME remodeling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Elevated CALB2 expression correlated significantly with poor prognosis in CRC patients. CALB2 knockdown suppressed CRC cell proliferation, migration, and colony formation, while promoting apoptosis. CALB2 silencing also reprogrammed  TME by inducing macrophage M1 polarization, enhancing CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cell cytotoxicity, and reducing immunosuppressive cell infiltration. Mechanistically, CALB2 activated the STAT3 signaling pathway to promote CCL5 secretion, facilitating M2 polarization of macrophages and activation of fibroblasts.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings identify CALB2 as a critical regulator of tumor progression and immune escape in CRC, acting through dual oncogenic and immunomodulatory mechanisms. CALB2 represents a promising therapeutic target for enhancing immunotherapy efficacy in CRC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1791363","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T05:45:00Z","timestamp":1776231900000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["CALB2 mediates tumor progression and immune escape in colorectal cancer by shaping an inhibitory immune microenvironment"],"prefix":"10.3389","volume":"17","author":[{"given":"Yibo","family":"Bian","sequence":"first","affiliation":[{"name":"State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Xijing Hospital, Fourth Military Medical University","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaonan","family":"Huangfu","sequence":"additional","affiliation":[{"name":"Department of Oncology, BenQ Hospital of Nanjing Medical University","place":["Nanjing, Jiangsu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Lu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Xijing Hospital, Fourth Military Medical University","place":["Xi\u2019an, Shaanxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33114","article-title":"Profiling global cancer incidence and mortality by socioeconomic development","volume":"147","author":"Lortet-Tieulent","year":"2020","journal-title":"Int J Cancer"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2020.08.002","article-title":"Integrated omics of metastatic colorectal cancer","volume":"38","author":"Li","year":"2020","journal-title":"Cancer Cell"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2025.11.051","article-title":"Burden profiles and mortality-attributable risk factors for gastrointestinal cancers: A comprehensive analysis, 1990-2021","author":"Fan","year":"2025","journal-title":"J Adv Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-023-01675-y","article-title":"The immunometabolic ecosystem in cancer","volume":"24","author":"Bantug","year":"2023","journal-title":"Nat Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-022-00547-1","article-title":"A timeline of tumour-associated macrophage biology","volume":"23","author":"Cassetta","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41568-024-00761-z","article-title":"Convergent inducers and effectors of T cell paralysis in the tumour microenvironment","volume":"25","author":"Hanahan","year":"2025","journal-title":"Nat Rev Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00540-z","article-title":"Fibroblasts as immune regulators in infection, inflammation and cancer","volume":"21","author":"Davidson","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-024-00743-1","article-title":"Macrophages and T cells in metabolic disorder-associated cancers","volume":"24","author":"Taranto","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.1c03562","article-title":"All-ion monitoring-directed low-abundance protein quantification reveals CALB2 as a key promoter in hepatocellular carcinoma metastasis","volume":"94","author":"Chu","year":"2022","journal-title":"Anal Chem"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.12749","article-title":"Upregulation of mesothelial genes in ovarian carcinoma cells is associated with an unfavorable clinical outcome and the promotion of cancer cell adhesion","volume":"14","author":"Ojasalu","year":"2020","journal-title":"Mol Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.3390\/ijms19124015","article-title":"Calretinin functions in malignant mesothelioma cells cannot be replaced by the closely related Ca(2+)-binding proteins calbindin-D28k and parvalbumin","volume":"19","author":"Worthmuller","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s13046-024-03201-w","article-title":"CALB2 drives pancreatic cancer metastasis through inflammatory reprogramming of the tumor microenvironment","volume":"43","author":"Tao","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15080","article-title":"Tumour-associated macrophages secrete pleiotrophin to promote PTPRZ1 signalling in glioblastoma stem cells for tumour growth","volume":"8","author":"Shi","year":"2017","journal-title":"Nat Commun"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202101235","article-title":"Smad3 promotes cancer-associated fibroblasts generation via macrophage-myofibroblast transition","volume":"9","author":"Tang","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","article-title":"Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: New findings and future perspectives","volume":"20","author":"Mao","year":"2021","journal-title":"Mol Cancer"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12978","article-title":"Role of cancer-associated fibroblast subpopulations in immune infiltration, as a new means of treatment in cancer","volume":"302","author":"Mhaidly","year":"2021","journal-title":"Immunol Rev"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-25-0663","article-title":"Extracellular vesicle-packaged miR-99a reprograms fibroblasts to create an inflammatory niche that drives colorectal cancer metastasis","volume":"86","author":"Zhou","year":"2026","journal-title":"Cancer Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.02.015","article-title":"Activated fibroblasts in cancer: Perspectives and challenges","volume":"41","author":"Caligiuri","year":"2023","journal-title":"Cancer Cell"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15289","article-title":"Stat3 regulates centrosome clustering in cancer cells via Stathmin\/PLK1","volume":"8","author":"Morris","year":"2017","journal-title":"Nat Commun"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-019-0279-0","article-title":"CCL5 deficiency promotes liver repair by improving inflammation resolution and liver regeneration through M2 macrophage polarization","volume":"17","author":"Li","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-310514","article-title":"Targeting of tumour-infiltrating macrophages via CCL2\/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma","volume":"66","author":"Li","year":"2017","journal-title":"Gut"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2023.06.017","article-title":"Hypoxic niches attract and sequester tumor-associated macrophages and cytotoxic T cells and reprogram them for immunosuppression","volume":"56","author":"Sattiraju","year":"2023","journal-title":"Immunity"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215972","article-title":"Single-cell RNA sequencing unveils the communications between malignant T and myeloid cells contributing to tumor growth and immunosuppression in cutaneous T-cell lymphoma","volume":"551","author":"Du","year":"2022","journal-title":"Cancer Lett"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-21-0316","article-title":"Spatiotemporal immune landscape of colorectal cancer liver metastasis at single-cell level","volume":"12","author":"Wu","year":"2022","journal-title":"Cancer Discov"},{"key":"B26","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s11064-025-04576-8","article-title":"CALB2 overexpression attenuates neuropathic pain by inhibiting oxidative stress and modulating microglia M1\/M2 polarization through activation of the cAMP\/CREB pathway","volume":"50","author":"Jin","year":"2025","journal-title":"Neurochem Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/s41419-023-06180-6","article-title":"Calbindin 2-specific deletion of arginase 2 preserves visual function after optic nerve crush","volume":"14","author":"Zaidi","year":"2023","journal-title":"Cell Death Dis"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1730793","article-title":"Serum calretinin as an independent predictor for platinum resistance and prognosis in ovarian cancer","volume":"146","author":"Link","year":"2020","journal-title":"Int J Cancer"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.138290","article-title":"Microdissected pancreatic cancer proteomes reveal tumor heterogeneity and therapeutic targets","volume":"5","author":"Le Large","year":"2020","journal-title":"JCI Insight"},{"key":"B30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41571-020-0403-1","article-title":"TGFbeta biology in cancer progression and immunotherapy","volume":"18","author":"Derynck","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41573-024-01098-w","article-title":"Targeting metabolic dysfunction of CD8 T cells and natural killer cells in cancer","volume":"24","author":"Viel","year":"2025","journal-title":"Nat Rev Drug Discov"},{"key":"B32","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cytogfr.2025.01.003","article-title":"Insights into IL-6\/JAK\/STAT3 signaling in the tumor microenvironment: Implications for cancer therapy","volume":"85","author":"Thuya","year":"2025","journal-title":"Cytokine Growth Factor Rev"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2017.12.003","article-title":"The role of STAT3 in leading the crosstalk between human cancers and the immune system","volume":"415","author":"Wang","year":"2018","journal-title":"Cancer Lett"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1736606","article-title":"IL-6\/STAT3 signaling in prostate cancer: CAF-driven immune evasion and therapeutic opportunities","volume":"16","author":"Zhou","year":"2025","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.gendis.2021.08.004","article-title":"CCL5\/CCR5 axis in human diseases and related treatments","volume":"9","author":"Zeng","year":"2022","journal-title":"Genes Dis"},{"key":"B36","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s13046-025-03552-y","article-title":"Targeting the CCL5\/CCR5 axis in tumor-stromal crosstalk to overcome cisplatin resistance in neuroendocrine prostate cancer","volume":"44","author":"Liu","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-024-01346-4","article-title":"Sorcin can trigger pancreatic cancer-associated new-onset diabetes through the secretion of inflammatory cytokines such as serpin E1 and CCL5","volume":"56","author":"Gong","year":"2024","journal-title":"Exp Mol Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1791363\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T05:45:01Z","timestamp":1776231901000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1791363\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":37,"alternative-id":["10.3389\/fimmu.2026.1791363"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1791363","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"article-number":"1791363"}}